文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

创伤炎症的免疫治疗选择

Immunotherapeutic options for inflammation in trauma.
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论综述指出,创伤后炎症免疫反应在器官功能恢复中作用日益受认可,未来可能通过调控炎症级联反应拓宽高危创伤患者的治疗窗口。

本文为综述,回顾创伤免疫学基本概念,梳理现有免疫治疗选项的结局获益,并指出未来研究方向。作者认为,随着创伤分子生物学不断阐明,血液成分治疗与止血仍是创伤救治的基本概念,而针对损伤的炎症免疫反应在器官功能恢复中作用日益受认可,或可通过调控创伤炎症级联反应拓宽高危创伤患者的治疗窗口。作者还指出,创伤有效治疗常需在伤后极早期实施,需开发可在创伤救治前线使用、成本效益好、便携且环境稳定的治疗;未来冲突中高级外科救治可及性可能有限,伤员后送外科医生前需复苏治疗。证据等级为综述III级。

要点

  • 血液成分治疗与出血控制仍是创伤救治的基本概念,炎症免疫反应在器官功能恢复中作用日益受认可。
  • 作者认为,创伤炎症级联反应或可被调控,以拓宽高危创伤患者的治疗窗口。
  • 创伤有效治疗常需伤后极早期实施,需开发可在创伤救治前线使用、成本效益好、便携且环境稳定的治疗。
  • 未来冲突中高级外科救治可及性可能有限,伤员后送外科医生前可能需要复苏治疗。
  • 证据等级:综述III级。

适用人群与场景

  • 高危创伤患者
  • 受伤的作战人员

研究设计与关键结果

  • 综述指出,过去20年创伤外科管理与当前冲突中的军事经验并行演进,广泛使用止血带、经验性给予新鲜冰冻血浆、空中重症监护单元等疗法曾受质疑,现已成为常见实践。
  • 作者认为,随着创伤分子生物学被阐明,研究方学也须发展以利用复苏的创新方法。
  • 作者认为,创伤的炎症免疫反应在器官功能恢复中作用日益受认可,或可通过调控创伤炎症级联反应拓宽高危创伤患者的治疗窗口。
  • 作者指出,创伤有效治疗常需伤后极早期实施,需开发可在创伤救治前线使用、成本效益好、便携且环境稳定的治疗。
  • 作者指出,未来冲突中高级外科救治可及性可能有限,伤员后送外科医生前需要复苏治疗,调控创伤炎症反应可能提供解决方案。

证据类型、等级与局限

  • 证据类型:综述。
  • 证据等级:III级。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为,创伤炎症级联反应或可被调控,以拓宽高危创伤患者的治疗窗口。
  • 作者指出,需开发可在创伤救治前线使用、成本效益好、便携且环境稳定的治疗,以便伤后极早期实施。
  • 作者指出,未来冲突中高级外科救治可及性可能有限,伤员后送外科医生前需要复苏治疗。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Surgical management of trauma in the last 20 years has evolved in parallel with the military's experience in the current conflicts. Therapies such as widespread tourniquet use, empiric administration of fresh frozen plasma, and airborne intensive care units had been viewed skeptically but are now common practice. There is an opportunity to expand the envelope of care even further through similarly innovative approaches and varied avenues of research.

RESULTS: As the molecular biology of trauma is elucidated, research methodologies must also be developed to capitalize on innovative approaches to resuscitation. Blood component therapy and control of bleeding remain as the fundamental concepts in trauma care. The inflammo-immune response to injury, however, plays an increasingly recognized role in recovery of organ function. Perhaps the inflammatory cascade of trauma can be manipulated to extend the treatment envelope of at risk trauma patients.In trauma, the additional challenge of delivering effective treatment, often required very early after injury, necessitates the development of treatments to be implemented on the front lines of trauma care that are cost-effective, portable, and environmentally stable. Future conflicts may not offer ready access to high-level surgical care; therefore, resuscitative therapies will be needed for wounded service members because they are evacuated to the surgeon. Manipulation of the inflammatory response to trauma may offer a solution. As our understanding of the immune response continues to develop, the potential for improved outcomes for the wounded expands.

CONCLUSION: A review of basic concepts in immunology is necessary to appreciate any potential impact of immunotherapeutic approaches to trauma and inflammation. An overview of current options will focus on outcome benefits of available therapies and suggest possible areas for future investigation. Quantitative approaches will leverage basic science to identify high-yield strategies to improve care of the injured combatant.

LEVEL OF EVIDENCE: Review, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Tobin JM, Gavitt BJ, Nomellini V, et al. Immunotherapeutic options for inflammation in trauma. J Trauma Acute Care Surg. 2020. PMID: 32740297. doi:10.1097/TA.0000000000002810

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。